Search

Neil P. Hammell

Examiner (ID: 9948, Phone: (571)270-5919 , Office: P/1636 )

Most Active Art Unit
1636
Art Unit(s)
1636, 1634
Total Applications
484
Issued Applications
164
Pending Applications
50
Abandoned Applications
284

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15513291 [patent_doc_number] => 10563223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Intergenic elements for enhancing gene expression [patent_app_type] => utility [patent_app_number] => 15/720116 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18726 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15720116 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/720116
Intergenic elements for enhancing gene expression Sep 28, 2017 Issued
Array ( [id] => 12660412 [patent_doc_number] => 20180111970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => LONG UNIFORM RECOMBINANT PROTEIN FIBERS [patent_app_type] => utility [patent_app_number] => 15/705185 [patent_app_country] => US [patent_app_date] => 2017-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26037 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705185 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/705185
Long uniform recombinant protein fibers Sep 13, 2017 Issued
Array ( [id] => 17287218 [patent_doc_number] => 11203759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-21 [patent_title] => Oxygen-responsive bacterial gene switch [patent_app_type] => utility [patent_app_number] => 15/698302 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10664 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698302 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/698302
Oxygen-responsive bacterial gene switch Sep 6, 2017 Issued
Array ( [id] => 12663847 [patent_doc_number] => 20180113115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT [patent_app_type] => utility [patent_app_number] => 15/693824 [patent_app_country] => US [patent_app_date] => 2017-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 324 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693824 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/693824
SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT Aug 31, 2017 Abandoned
Array ( [id] => 13690177 [patent_doc_number] => 20170356043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME [patent_app_type] => utility [patent_app_number] => 15/684845 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684845 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/684845
ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME Aug 22, 2017 Abandoned
Array ( [id] => 16925265 [patent_doc_number] => 11046727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Methods for isolation, identification, and quantification of miRNAs [patent_app_type] => utility [patent_app_number] => 15/682103 [patent_app_country] => US [patent_app_date] => 2017-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 11813 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682103 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/682103
Methods for isolation, identification, and quantification of miRNAs Aug 20, 2017 Issued
Array ( [id] => 12206121 [patent_doc_number] => 20180051348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'PREDICTION OF LIKELIHOOD OF CANCER RECURRENCE' [patent_app_type] => utility [patent_app_number] => 15/674817 [patent_app_country] => US [patent_app_date] => 2017-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12689 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674817 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/674817
Prediction of likelihood of cancer recurrence Aug 10, 2017 Issued
Array ( [id] => 12409278 [patent_doc_number] => 09970026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides [patent_app_type] => utility [patent_app_number] => 15/665155 [patent_app_country] => US [patent_app_date] => 2017-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 27 [patent_no_of_words] => 53642 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15665155 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/665155
Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides Jul 30, 2017 Issued
Array ( [id] => 12409281 [patent_doc_number] => 09970027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides [patent_app_type] => utility [patent_app_number] => 15/665201 [patent_app_country] => US [patent_app_date] => 2017-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 27 [patent_no_of_words] => 53705 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15665201 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/665201
Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides Jul 30, 2017 Issued
Array ( [id] => 13609697 [patent_doc_number] => 20180356398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => LIVING TISSUE MODEL DEVICE, VASCULAR WALL MODEL, VASCULAR WALL MODEL DEVICE AND METHOD OF EVALUATING TEST SUBSTANCE [patent_app_type] => utility [patent_app_number] => 15/618150 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15665 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618150 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/618150
LIVING TISSUE MODEL DEVICE, VASCULAR WALL MODEL, VASCULAR WALL MODEL DEVICE AND METHOD OF EVALUATING TEST SUBSTANCE Jun 8, 2017 Abandoned
Array ( [id] => 11971541 [patent_doc_number] => 20170275695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'METHODS AND SYSTEMS FOR MONITORING, DIAGNOSING, AND TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE' [patent_app_type] => utility [patent_app_number] => 15/618075 [patent_app_country] => US [patent_app_date] => 2017-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 32707 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/618075
Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease Jun 7, 2017 Issued
Array ( [id] => 12641199 [patent_doc_number] => 20180105564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS [patent_app_type] => utility [patent_app_number] => 15/609983 [patent_app_country] => US [patent_app_date] => 2017-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10144 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609983 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/609983
USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS May 30, 2017 Abandoned
Array ( [id] => 13703269 [patent_doc_number] => 20170362589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => DE NOVO SYNTHESIZED GENE LIBRARIES [patent_app_type] => utility [patent_app_number] => 15/603013 [patent_app_country] => US [patent_app_date] => 2017-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 115997 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603013 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/603013
DE NOVO SYNTHESIZED GENE LIBRARIES May 22, 2017 Abandoned
15/600305 Protection of Cells from Degeneration and Treatment of Geographic Atrophy May 18, 2017 Abandoned
Array ( [id] => 13888305 [patent_doc_number] => 10196698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-05 [patent_title] => DNA methylation markers for metastatic prostate cancer [patent_app_type] => utility [patent_app_number] => 15/598684 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 43 [patent_no_of_words] => 22327 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598684 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/598684
DNA methylation markers for metastatic prostate cancer May 17, 2017 Issued
Array ( [id] => 17045166 [patent_doc_number] => 11098335 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => Expression system [patent_app_type] => utility [patent_app_number] => 15/588851 [patent_app_country] => US [patent_app_date] => 2017-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 10602 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588851 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/588851
Expression system May 7, 2017 Issued
Array ( [id] => 11942474 [patent_doc_number] => 20170246625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'GENETIC SAMPLE COLLECTION SYSTEMS' [patent_app_type] => utility [patent_app_number] => 15/491248 [patent_app_country] => US [patent_app_date] => 2017-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8232 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15491248 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/491248
GENETIC SAMPLE COLLECTION SYSTEMS Apr 18, 2017 Abandoned
Array ( [id] => 12001799 [patent_doc_number] => 20170305955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'Reprogramming of Cellular Adhesion' [patent_app_type] => utility [patent_app_number] => 15/482591 [patent_app_country] => US [patent_app_date] => 2017-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 24875 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482591 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/482591
Reprogramming of cellular adhesion Apr 6, 2017 Issued
Array ( [id] => 11866522 [patent_doc_number] => 20170233807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'Epigenetic Markers for the Identification of Blood Sub-cells of Type 1' [patent_app_type] => utility [patent_app_number] => 15/477768 [patent_app_country] => US [patent_app_date] => 2017-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7570 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477768 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/477768
Epigenetic Markers for the Identification of Blood Sub-cells of Type 1 Apr 2, 2017 Abandoned
Array ( [id] => 13703379 [patent_doc_number] => 20170362644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => METHODS AND COMPOSITIONS FOR DETECTING A TARGET RNA [patent_app_type] => utility [patent_app_number] => 15/467922 [patent_app_country] => US [patent_app_date] => 2017-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77152 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467922 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/467922
Methods and compositions for detecting a target RNA Mar 22, 2017 Issued
Menu